Global Brain Cancer Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Brain Cancer Diagnostics Market is presumed to reach the market size of nearly USD 4.26 BN by 2030 from USD 2.5 BN in 2022 with a CAGR of 6.9% under the study period 2023 - 2030.

Brain cancer diagnostics involve the identification, assessment, and determination of brain tumors or cancers through various medical procedures, tests, and imaging techniques. These diagnostics are crucial in accurately diagnosing brain tumors, determining their characteristics, location, and size, and grading the cancer's severity.

MARKET DYNAMICS:

The brain cancer diagnostics market experiences growth propelled by diverse factors at the intersection of technological advancements, rising disease incidence, and healthcare awareness. Advancements in imaging technologies drive the demand for more precise and early detection capabilities. The increasing prevalence of brain tumors worldwide amplifies the need for accurate diagnostic tools and procedures to facilitate early detection and timely intervention. Heightened awareness campaigns and screening initiatives further drive the demand for diagnostic tests among at-risk populations. Technological innovations in biopsy techniques and genetic testing contribute to more precise tumor characterization, aiding in personalized treatment approaches. Moreover, the preference for non-invasive diagnostic methods fosters the development of less invasive techniques. Government support, research funding, and collaborations between diagnostic firms and healthcare institutions foster innovation and the development of advanced brain cancer diagnostic solutions. Collectively, these factors fuel the growth of the brain cancer diagnostics market, promoting the creation of more effective, patient-friendly diagnostic tools for early detection and tailored treatment strategies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of brain cancer diagnostics. The growth and trends of brain cancer diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the brain cancer diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Diagnostic Technique

Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat)
Tissue Sampling/Biopsy
Molecular Diagnostics
Others

By Brain Cancer Type

Gliomas
Meningiomas
Pituitary Tumors
Others

By End-User

Hospitals
Diagnostic Laboratories
Cancer Hospitals/Centers

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Brain Cancer Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Brain Cancer Diagnostics market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Thermo Fisher Scientific, Rare Diagnostics, Abbott Laboratories, Illumina Inc, Hologic Inc, Agilent Technologies, Bio Rad Laboratories. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112112878

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BRAIN CANCER DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Diagnostic Technique
- 3.7.2 Market Attractiveness Analysis By Brain Cancer Type
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY DIAGNOSTIC TECHNIQUE

5.1 Overview by Diagnostic Technique
5.2 Historical and Forecast Data
5.3 Analysis by Diagnostic Technique
5.4 Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (C1) Scan, PET Scan or PE CT Scam, Single-photon Emission Computed Tomography (SPECT) Scat) Historic and Forecast Sales by Regions
5.5 Tissue Sampling/Biopsy Historic and Forecast Sales by Regions
5.6 Molecular Diagnostics Historic and Forecast Sales by Regions
5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY BRAIN CANCER TYPE

6.1 Overview by Brain Cancer Type
6.2 Historical and Forecast Data
6.3 Analysis by Brain Cancer Type
6.4 Gliomas Historic and Forecast Sales by Regions
6.5 Meningiomas Historic and Forecast Sales by Regions
6.6 Pituitary Tumors Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Diagnostic Laboratories Historic and Forecast Sales by Regions
7.6 Cancer Hospitals/Centers Historic and Forecast Sales by Regions

8 . GLOBAL BRAIN CANCER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE BRAIN CANCER DIAGNOSTICS COMPANIES

9.1. Brain Cancer Diagnostics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF BRAIN CANCER DIAGNOSTICS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. GE Healthcare
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Siemens Healthineers
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Philips Healthcare
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Thermo Fisher Scientific
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Rare Diagnostics
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Abbott Laboratories
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Illumina Inc
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Hologic Inc
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Agilent Technologies
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Bio Rad Laboratories
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies